Document is current
Any future updates will be listed below
-
Authors
Talay, Angelo
Belikov, Aleksey V.
To, Paul Ka Po
Alfatemi, Hamid H.
Alon, Uri
Deelen, Joris
Ewald, Collin Y.
Gems, David
Gorbunova, Vera
Gruber, Jan
Hägg, Sara
Hemming, John
Horvath, Steve
Kaya, Alaattin
Lewis, Caitlin J.
Maier, Andrea B.
Marinova, Maria B.
Pawelec, Graham
Peleg, Shahaf
Rattan, Suresh
Scheibye-Knudsen, Morten
Schmauck-Medina, Tomas
Saroyan, Vardan
Seluanov, Andrei
Stolzing, Alexandra
Teeling, Emma
Williams, Robert W.
White, Todd
Unfried, Maximilian
de Magalhães, João Pedro
-
Funding
Funding for this research was provided by:
Longevity Impetus Grant
- License Information
-
More Information
Article History
Received: 1 August 2025
Accepted: 17 October 2025
First Online: 8 November 2025
Change Date: 30 November 2025
Change Type: Update
Change Details: An ESM files has been added.
Declarations
:
: JPM is CSO of YouthBio Therapeutics, an advisor/consultant for the BOLD Longevity Growth Fund and NOVOS, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science. SH is a founder and paid consultant of the non-profit Epigenetic Clock Development Foundation and a Principal Investigator at the Altos Labs, Cambridge Institute of Science, a biomedical company that works on rejuvenation. With no relation to the present manuscript, CYE declares to be a co-founder and shareholder of Avea Life AG and Lichi3 GmbH and is employed by Novartis.
